1. Home
  2. GFAI vs HCWB Comparison

GFAI vs HCWB Comparison

Compare GFAI & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardforce AI Co. Limited

GFAI

Guardforce AI Co. Limited

HOLD

Current Price

$0.36

Market Cap

15.9M

ML Signal

HOLD

HCWB

HCW Biologics Inc.

HOLD

Current Price

$3.22

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFAI
HCWB
Founded
2018
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
14.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GFAI
HCWB
Price
$0.36
$3.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.50
$35.00
AVG Volume (30 Days)
159.6K
61.4K
Earning Date
04-21-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.37
Revenue
N/A
$4,099,750.00
Revenue This Year
$14.12
N/A
Revenue Next Year
$10.25
N/A
P/E Ratio
N/A
$9.14
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.25
52 Week High
$1.38
$7.35

Technical Indicators

Market Signals
Indicator
GFAI
HCWB
Relative Strength Index (RSI) 47.38 52.15
Support Level $0.31 $0.37
Resistance Level $0.42 $4.00
Average True Range (ATR) 0.03 0.44
MACD 0.01 -0.03
Stochastic Oscillator 61.90 50.53

Price Performance

Historical Comparison
GFAI
HCWB

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: